LeukoSTATTM - Finally, Targeting Inflammation at is Source
LeukoSTAT™ was developed by immunologists, veterinarians and scientists to target inflammation at its source, being inflammatory cells (leukocytes). LeukoSTAT™ contains the ImSAIDs®, natural patented amino acid complexes which have been evaluated in models of allergies, pancreatitis, anaphylaxis, sepsis, asthma, and other frustrating conditions.
IMULAN BioTherapeutics, LLC has exclusively licensed the global veterinary rights to the ImSAIDs breakthrough technology platform. LeukoSTAT has been specifically designed for inflammatory conditions where other products may not work or be contraindicated.
LeukoSTAT is ideal for inflammation associated with the pancreas, liver, intestine, lungs, skin, and joints.
IMULAN BioTherapeutics, LLC has exclusively licensed the global veterinary rights to the ImSAIDs breakthrough technology platform. LeukoSTAT has been specifically designed for inflammatory conditions where other products may not work or be contraindicated.
LeukoSTAT is ideal for inflammation associated with the pancreas, liver, intestine, lungs, skin, and joints.
LeukoSTATTM is available in 30 and 120 count bottles. Each tablet is designed to be highly palatable.Download LeukoSTAT Technical Trifold
To Order; Contact:
IMULAN BioTherapeutics, LLC
Kit Bond Science and Technology Incubator
4221 Michell Avenue
St. Joseph, MO 64507
816.749.4016
Click here to visit IMULAN's website
IMULAN BioTherapeutics, LLC
Kit Bond Science and Technology Incubator
4221 Michell Avenue
St. Joseph, MO 64507
816.749.4016
Click here to visit IMULAN's website